Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tetra Bio Pharma Inc (TBP.TO)

Tetra Bio Pharma Inc (TBP.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 23,263
  • Shares Outstanding, K 422,968
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,175 K
  • 60-Month Beta 2.09
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 44.14
Trade TBP.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings 0.00 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0500 +10.00%
on 06/20/22
0.0700 -21.43%
on 06/14/22
-0.0050 (-8.33%)
since 05/24/22
3-Month
0.0500 +10.00%
on 06/20/22
0.0800 -31.25%
on 03/25/22
-0.0200 (-26.67%)
since 03/24/22
52-Week
0.0500 +10.00%
on 06/20/22
0.3600 -84.72%
on 06/25/21
-0.3000 (-84.51%)
since 06/24/21

Most Recent Stories

More News
Stocks in play: Tetra Bio-Pharma Inc

Announces the launch of its new wholly owned subsidiary 'Tetra Bio-Pharma Australia Pty Ltd', an Australian-based ...

TBP.TO : 0.0550 (unch)
Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development...

TBP.TO : 0.0550 (unch)
TBPMF : 0.0464 (+3.57%)
Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development,...

TBPMF : 0.0464 (+3.57%)
TBP.TO : 0.0550 (unch)
Stocks in play: Tetra Bio-Pharma Inc.

Announced the appointment of Leslie Auld, H.BSc, MBA, CPA, as Chief Financial Officer and member of ...

TBP.TO : 0.0550 (unch)
Tetra Bio-Pharma Appoints Chief Financial Officer

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoid-derived drug discovery and development...

TBPMF : 0.0464 (+3.57%)
TBP.TO : 0.0550 (unch)
Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development...

TBPMF : 0.0464 (+3.57%)
TBP.TO : 0.0550 (unch)
Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development,...

TBPMF : 0.0464 (+3.57%)
TBP.TO : 0.0550 (unch)
Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development in...

TBP.TO : 0.0550 (unch)
TBPMF : 0.0464 (+3.57%)
Tetra Bio-Pharma and Cannvalate Enter Into Partnership

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development,...

TBP.TO : 0.0550 (unch)
TBPMF : 0.0464 (+3.57%)
REPEAT – Tetra Bio-Pharma Announces Pricing of Marketed Public Offering of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OTTAWA, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc....

OTC.VN : 0.340 (+9.68%)
TBP.TO : 0.0550 (unch)
TBPMF : 0.0464 (+3.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0633
2nd Resistance Point 0.0617
1st Resistance Point 0.0583
Last Price 0.0550
1st Support Level 0.0533
2nd Support Level 0.0517
3rd Support Level 0.0483

See More

52-Week High 0.3600
Fibonacci 61.8% 0.2416
Fibonacci 50% 0.2050
Fibonacci 38.2% 0.1684
Last Price 0.0550
52-Week Low 0.0500

See More

Business Summary

Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an advanced and...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar